KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2025)

Aurora Cannabis has reported Liabilities and Shareholders Equity over the past 8 years, most recently at $556.0 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 10.37% to $556.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, down 5.88% year-over-year, with the annual reading at $594.2 million for FY2025, 4.52% down from the prior year.
  • Liabilities and Shareholders Equity was $556.0 million for Q4 2025 at Aurora Cannabis, up from $550.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.8 billion in Q3 2021 and troughed at $550.0 million in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $621.3 million (2024), against an average of $1.0 billion.
  • Year-over-year, Liabilities and Shareholders Equity rose 5.57% in 2021 and then plummeted 68.4% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.0 billion in 2021, then crashed by 61.75% to $754.3 million in 2022, then dropped by 20.42% to $600.2 million in 2023, then rose by 3.34% to $620.3 million in 2024, then dropped by 10.37% to $556.0 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Liabilities and Shareholders Equity are $556.0 million (Q4 2025), $550.0 million (Q3 2025), and $604.7 million (Q2 2025).